Rick Morgan

Rick Morgan, Ph.D. has had a long and successful career in the biopharma industry. Rick began their career in 1998 as Interim Chief of the Clinical Gene Therapy Branch at the National Human Genome Research Institute. In 2001, they moved to the Surgery Branch at the National Cancer Institute, National Institutes of Health, where they served as a Staff Scientist. In 2013, they joined bluebird bio as Vice President of Immunotherapy. In 2018, they were appointed Senior Vice President at Editas Medicine, and in 2021 they were appointed Chief Scientific Officer at Be Biopharma.

Rick Morgan, Ph.D. received their Doctor of Philosophy (PhD) in Genetics from The Johns Hopkins University between 1981 and 1987. Prior to that, they earned their Bachelor of Arts (BA) in Biochemistry from Brandeis University between 1977 and 1981.